NCT05222945 A Study to Determine the Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing bictégravir, Emtricitabine and ténofovir alafénamide Status NOT_YET_RECRUITING Phase NA
NCT05186974 Study of Sacituzumab Govitecan Combinations in First-line Treatment of Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05177926 Preventing Mother-to-child Transmission of Hepatitis B Virus With Tenofovir Alafenamide (TAF) Status UNKNOWN Phase PHASE4
NCT05175339 Long-term Impact in Intensive Care Survivors of Coronavirus Disease (COVID-19) Status COMPLETED Phase N/A
NCT05169944 Magrolimab in Children and Adults With Recurrent or Progressive Malignant Brain Tumors Status COMPLETED Phase PHASE1
NCT05165771 Study to Evaluate Safety, Tolerability, and Efficacy of GS-5718 in Participants With Active Rheumatoid Arthritis Who Have an Inadequate Response to Disease-modifying Antirheumatic Drug(s) (bDMARDs) Treatment Status WITHDRAWN Phase PHASE2
NCT05147740 Study to Assess Switching to B/F/TAF in Treatment Experienced People With HIV Who Are at Least 65 Years of Age Status UNKNOWN Phase PHASE4
NCT05143229 Alpelisib And Sacituzumab Govitecan For Treatment Of Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05140941 Sofosbuvir/Velpatasvir Treatment of Chronic Hepatitis C During Pregnancy Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT05119907 Study of Sacituzumab Govitecan in Patients With Solid Tumor Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05111119 Making PrEP Smart: An HIV Testing and PrEP Electronic Support Tool ("SmartPrEP" App) for Women on PrEP Status COMPLETED Phase NA
NCT05101096 Study of Sacituzumab Govitecan (SG) in Japanese Participants With Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05097599 StrataPATH™ (Precision Indications for Approved Therapies) Status TERMINATED Phase PHASE2
NCT05095818 Impact of Nursing Involvement on Implementation of HIV Prevention Services Status COMPLETED Phase NA
NCT05090410 Efficacy and Safety of Selective JAK 1 Inhibitor Filgotinib in Active Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate Status UNKNOWN Phase PHASE3
NCT05089734 Study of Sacituzumab Govitecan (SG) Versus Docetaxel in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) Status ACTIVE_NOT_RECRUITING Phase PHASE3